Cargando…

Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic

For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization...

Descripción completa

Detalles Bibliográficos
Autores principales: Schellhase, Ellen, Stanko, Madeline, Kinstler, Natalie, Miller, Monica L., Antoniou, Sotiris, Fhadil, Sadeer, Patel, Mital, Wright, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037589/
https://www.ncbi.nlm.nih.gov/pubmed/36961026
http://dx.doi.org/10.3390/pharmacy11020048
_version_ 1784911913642098688
author Schellhase, Ellen
Stanko, Madeline
Kinstler, Natalie
Miller, Monica L.
Antoniou, Sotiris
Fhadil, Sadeer
Patel, Mital
Wright, Paul
author_facet Schellhase, Ellen
Stanko, Madeline
Kinstler, Natalie
Miller, Monica L.
Antoniou, Sotiris
Fhadil, Sadeer
Patel, Mital
Wright, Paul
author_sort Schellhase, Ellen
collection PubMed
description For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization of cholesterol/lipids to prevent unfavorable outcomes, such as stroke and other cardiovascular complications. Delays to initiating anticoagulation can have devastating consequences. We sought to implement a virtual clinic, where a pharmacist reviews patient referrals from a CIED clinic after detecting AF from the CIED. Anticoagulation choice is determined by patient-specific factors, and a shared patient–provider decision to start oral anticoagulation is made. In addition, blood pressure readings and medications are assessed with lipid-lowering therapies for optimization. A total of 315 patients have been admitted through this clinic and anticoagulated over a two-year span; in addition, 322 successful interventions were made for optimization of cardiac therapy. Rapid initiation of anticoagulation within five days of referral was likely to have reduced unfavorable outcomes, such as stroke and other cardiovascular optimizations, leading to improved patient outcomes.
format Online
Article
Text
id pubmed-10037589
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100375892023-03-25 Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic Schellhase, Ellen Stanko, Madeline Kinstler, Natalie Miller, Monica L. Antoniou, Sotiris Fhadil, Sadeer Patel, Mital Wright, Paul Pharmacy (Basel) Communication For patients with cardiac implantable electronic devices (CIEDs), arrythmias such as atrial fibrillation (AF) can be detected and actions taken to rapidly assess and initiate treatment where appropriate. Actions include timely initiation of anticoagulation, review of blood pressure, and optimization of cholesterol/lipids to prevent unfavorable outcomes, such as stroke and other cardiovascular complications. Delays to initiating anticoagulation can have devastating consequences. We sought to implement a virtual clinic, where a pharmacist reviews patient referrals from a CIED clinic after detecting AF from the CIED. Anticoagulation choice is determined by patient-specific factors, and a shared patient–provider decision to start oral anticoagulation is made. In addition, blood pressure readings and medications are assessed with lipid-lowering therapies for optimization. A total of 315 patients have been admitted through this clinic and anticoagulated over a two-year span; in addition, 322 successful interventions were made for optimization of cardiac therapy. Rapid initiation of anticoagulation within five days of referral was likely to have reduced unfavorable outcomes, such as stroke and other cardiovascular optimizations, leading to improved patient outcomes. MDPI 2023-03-03 /pmc/articles/PMC10037589/ /pubmed/36961026 http://dx.doi.org/10.3390/pharmacy11020048 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Schellhase, Ellen
Stanko, Madeline
Kinstler, Natalie
Miller, Monica L.
Antoniou, Sotiris
Fhadil, Sadeer
Patel, Mital
Wright, Paul
Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic
title Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic
title_full Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic
title_fullStr Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic
title_full_unstemmed Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic
title_short Analysis of Pharmacy Cardiac Optimization Clinic for Patients with New Onset Atrial Fibrillation Detected via Cardiac Implantable Electronic Device Clinic
title_sort analysis of pharmacy cardiac optimization clinic for patients with new onset atrial fibrillation detected via cardiac implantable electronic device clinic
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037589/
https://www.ncbi.nlm.nih.gov/pubmed/36961026
http://dx.doi.org/10.3390/pharmacy11020048
work_keys_str_mv AT schellhaseellen analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic
AT stankomadeline analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic
AT kinstlernatalie analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic
AT millermonical analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic
AT antoniousotiris analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic
AT fhadilsadeer analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic
AT patelmital analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic
AT wrightpaul analysisofpharmacycardiacoptimizationclinicforpatientswithnewonsetatrialfibrillationdetectedviacardiacimplantableelectronicdeviceclinic